B
BioVie Inc. (BIVI)
NCM – Real Time Price. Currency in USD
1.32
-0.03 (-2.22%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.32
-0.03 (-2.22%)
At close: May 12, 2026, 4:00 PM EDT
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease; and in Phase 2 clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.
| Name | Position |
|---|---|
| Dr. Christopher L. Reading Ph.D. | Senior Vice President of Alzheimer's Disease Program |
| Dr. Joseph M. Palumbo M.D. | Executive VP of R&D and Chief Medical Officer |
| Dr. Penelope Markham Ph.D. | Senior Vice President of Liver Disease Program |
| Mr. Clarence N. Ahlem | Senior Vice President of Operations |
| Mr. Cuong Viet Do M.B.A. | President, CEO & Director |
| Mr. David Morse | Senior VP & Chief Regulatory Officer |
| Ms. Denise Smith | Senior Vice President of Manufacturing & Development |
| Ms. Joanne Wendy Kim CPA | CFO, Treasurer & Corporate Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-02-06 | 10-Q | bivi-20251231_10q.htm |
| 2025-11-25 | S-8 | bivi_s8.htm |
| 2025-11-13 | 8-K | bivi-20251113_8k.htm |
| 2025-11-12 | 8-K | bivi-20251110_8k.htm |
| 2025-11-10 | 10-Q | bivi-20250930_10q.htm |
| 2025-10-06 | POS AM | bivi_posam.htm |
| 2025-09-25 | DEF 14A | bivi-def14a.htm |
| 2025-08-15 | 10-K | bivi-20250630_10k.htm |
| 2025-08-11 | 8-K | bivi-20250807_8k.htm |
| 2025-08-07 | 8-A12B | bivi-8a12b.htm |